Literature DB >> 15549388

Co-reactivity of plasmodial histidine-rich protein 2 and aldolase on a combined immuno-chromographic-malaria dipstick (ICT) as a potential semi-quantitative marker of high Plasmodium falciparum parasitaemia.

Joachim Richter1, Klaus Göbels, Irmela Müller-Stöver, Barbara Hoppenheit, Dieter Häussinger.   

Abstract

The combined immuno-chromographic-malaria dipstick (ICT) for the rapid diagnosis of malaria detects both Plasmodium falciparum (P.f.)-specific, histidine-rich protein 2 (HRP-2) and a plasmodial aldolase expressed by all Plasmodium species pathogenic to humans. ICT was applied in 674 febrile returnees from malaria-endemic regions attending our Tropical Diseases Unit. Microscopy confirmed malaria in 69/674 cases, of whom 67/69 had returned from Africa or Madagascar, and 2/69 from the Caribbean. Monoparasitic P.f. infection occurred in 52/69, mixed infection was due to P.f.+ P. ovale (P.o.) in 3/69, and P.f.+P. malariae (P.m.) in 1/69 cases. Monoparasitic P. vivax (P.v.) infection occurred in 8/69 , P.o. in 3/69, and P.m. in 2/69 cases . Whereas a positive HRP-2 band on the test was a highly sensitive indicator for P.f. infection (52/52 patients; sensitivity 100%), this was not the case for a positive aldolase band (25/52 patients; sensitivity 48.1%). Sensitivity of aldolase band for non-falciparum plasmodia was even lower: aldolase was positive in only 3/8 (37.5%) of patients with vivax malaria, and in 0/5 cases with P.o.- or P.m. infection. Co-reaction of both bands occurred more frequently in patients with P.f. parasitaemia of > or =40,000/microl (20/25, 80.0%) as compared to patients with P.f. parasitaemia <40,000/microl (5/27, 18.5%; P<0.00005), and to patients with mixed infection (P.f.+ P.o., P.f.+ P.m.: 2/4, 50.0%; diff. n.s.). In our series, co-reaction of HRP-2 and aldolase indicated monoparasitic falciparum malaria with high P.f. parasitaemia, rather than mixed infection. Whereas the aldolase band is not a reliable qualitative marker for malaria, co-reaction of HRP-2 and aldolase band may have a potential for indicating high parasitaemia in falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15549388     DOI: 10.1007/s00436-004-1213-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  3 in total

1.  Performance of an immunochromatographic test for the rapid diagnosis of malaria.

Authors:  Joachim Richter; Gundel Harms; Irmela Müller-Stöver; Klaus Göbels; Dieter Häussinger
Journal:  Parasitol Res       Date:  2004-03-09       Impact factor: 2.289

2.  Evaluation of the ICT malaria P.f/P.v and the OptiMal rapid diagnostic tests for malaria in febrile returned travellers.

Authors:  E Geoffrey Playford; John Walker
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Comparison of two commercial assays with expert microscopy for confirmation of symptomatically diagnosed malaria.

Authors:  Jamshaid Iqbal; Nabila Khalid; Parsotam R Hira
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

  3 in total
  20 in total

1.  New developments in malaria diagnostics: monoclonal antibodies against Plasmodium dihydrofolate reductase-thymidylate synthase, heme detoxification protein and glutamate rich protein.

Authors:  Johanna H Kattenberg; Inge Versteeg; Stephanie J Migchelsen; Iveth J González; Mark D Perkins; Petra F Mens; Henk D F H Schallig
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

Review 2.  Update on rapid diagnostic testing for malaria.

Authors:  Clinton K Murray; Robert A Gasser; Alan J Magill; R Scott Miller
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

3.  Production of monoclonal antibodies for Plasmodium vivax lactate dehydrogenase and patient sera screening using sandwich ELISA.

Authors:  Jong-Hyun Kim; Jinyoung Lee; Hae-Jin Sohn; Hyun-Ok Song; Jung-Yeon Kim; Won-Ja Lee; Hyun Park; Ho-Joon Shin
Journal:  Parasitol Res       Date:  2012-06-28       Impact factor: 2.289

Review 4.  Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries.

Authors:  Katharine Abba; Jonathan J Deeks; Piero Olliaro; Cho-Min Naing; Sally M Jackson; Yemisi Takwoingi; Sarah Donegan; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

Review 5.  Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries.

Authors:  Katharine Abba; Amanda J Kirkham; Piero L Olliaro; Jonathan J Deeks; Sarah Donegan; Paul Garner; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2014-12-18

Review 6.  Malaria Rapid Diagnostic Tests: Literary Review and Recommendation for a Quality Assurance, Quality Control Algorithm.

Authors:  Michael J Kavanaugh; Steven E Azzam; David M Rockabrand
Journal:  Diagnostics (Basel)       Date:  2021-04-25

7.  Evaluation of the NOW Malaria Immunochromatographic Test for Quantitative Diagnosis of Falciparum and Vivax Malaria Parasite Density.

Authors:  Yuko Katakai; Kanako Komaki-Yasuda; Noppadon Tangpukdee; Polrat Wilairatana; Srivicha Krudsood; Shigeyuki Kano
Journal:  Trop Med Health       Date:  2011-12-01

8.  Test characteristics of the SD FK80 Plasmodium falciparum/Plasmodium vivax malaria rapid diagnostic test in a non-endemic setting.

Authors:  Philippe Gillet; David P J van Dijk; Emmanuel Bottieau; Lieselotte Cnops; Marjan Van Esbroeck; Jan Jacobs
Journal:  Malar J       Date:  2009-11-22       Impact factor: 2.979

9.  Use of a Dual-Antigen Rapid Diagnostic Test to Screen Children for Severe Plasmodium falciparum Malaria in a High-Transmission, Resource-Limited Setting.

Authors:  Ross Boyce; Raquel Reyes; Michael Matte; Moses Ntaro; Edgar Mulogo; Mark J Siedner
Journal:  Clin Infect Dis       Date:  2017-10-16       Impact factor: 9.079

10.  Comparative evaluation of bivalent malaria rapid diagnostic tests versus traditional methods in field with special reference to heat stability testing in Central India.

Authors:  Neeru Singh; Praveen K Bharti; Mrigendra P Singh; Sweta Mishra; Man M Shukla; Ravendra K Sharma; Rajesh K Singh
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.